It is vital for appropriate subtype specific monitoring (for example, cardiac or respiratory involvement in some subtypes) and any available therapy. Enrollment in clinical trials also requires information of the patientís specific type of LGMD.
It is vital for appropriate subtype specific monitoring (for example, cardiac or respiratory involvement in some subtypes) and any available therapy. Enrollment in clinical trials also requires information of the patientís specific type of LGMD.